Gain an understanding of patient advocacy communities, changing capacities and expectations, and emerging best practices in fostering partnerships between life science organizations and patient organizations.

Learning objectives

Explain the rationale for partnering with patients Describe different types of patient organizations and existing resources to help identify those whose objectives and capabilities are best positioned to align with stated project goals List factors to consider in timing the approach to patient organizations Draw upon existing open source resources to reduce uncertainty about terms of and conditions for partnering activities Identify criteria for meaningful, quality engagements with patient organizations to guide interactions and contracting List common challenges with partnering with patient organizations and ways to mitigate them

Owner (organization)

PFMD

Target audience

Patients, Patient organisation, Regulators, Pharmaceutical companies or industry , Researchers (investigators and academic researchers), Other, Patient advocate

Types

Training, Guidance

Formats

Online e-learning

Levels

Unknown

Language

English

Accessibility

Not applicable

Certification

No

Patients involved

No

Length of training (in hrs)

3

PFMD last access

28 Nov 2020

Organizations